C07D 241/42
With only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to
Official title: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
C07D241/42 (With only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to) appears on 523 US grants and 495 published applications in this corpus.
Search patents in C07D- Granted patents
- 523
- Published applications
- 495
- Assignees
- 304
- Inventors
- 1,768
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 4 | 0 |
| 1978 | 7 | 0 |
| 1979 | 4 | 0 |
| 1980 | 5 | 0 |
| 1981 | 1 | 0 |
| 1982 | 5 | 0 |
| 1983 | 1 | 0 |
| 1984 | 4 | 0 |
| 1985 | 2 | 0 |
| 1986 | 3 | 0 |
| 1987 | 3 | 0 |
| 1988 | 6 | 0 |
| 1989 | 5 | 0 |
| 1990 | 5 | 0 |
| 1991 | 4 | 0 |
| 1992 | 6 | 0 |
| 1993 | 7 | 0 |
| 1994 | 6 | 0 |
| 1995 | 9 | 0 |
| 1996 | 11 | 0 |
| 1997 | 12 | 0 |
| 1998 | 23 | 0 |
| 1999 | 15 | 0 |
| 2000 | 6 | 0 |
| 2001 | 16 | 6 |
| 2002 | 10 | 12 |
| 2003 | 17 | 21 |
| 2004 | 12 | 32 |
| 2005 | 6 | 32 |
| 2006 | 15 | 15 |
| 2007 | 12 | 19 |
| 2008 | 15 | 21 |
| 2009 | 18 | 21 |
| 2010 | 11 | 29 |
| 2011 | 19 | 20 |
| 2012 | 23 | 16 |
| 2013 | 13 | 14 |
| 2014 | 13 | 14 |
| 2015 | 14 | 22 |
| 2016 | 26 | 26 |
| 2017 | 15 | 15 |
| 2018 | 16 | 18 |
| 2019 | 12 | 17 |
| 2020 | 16 | 17 |
| 2021 | 13 | 22 |
| 2022 | 11 | 20 |
| 2023 | 11 | 20 |
| 2024 | 4 | 16 |
| 2025 | 12 | 16 |
| 2026 | 14 | 14 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Tautomeric ligand enables biomimetic C—H hydroxylation with molecular oxygen22 Sep 2026US 12,741,937 B2The Scripps Research Institute
- RNA-targeting ligands, compositions thereof, and methods of making and using the same22 Sep 2026US 12,741,945 B2The University of North Carolina at Chapel Hill
- Organic material composition and applications thereof23 Jun 2026US 12,662,472 B2Ningbo Lumilan Advanced Materials Co., Ltd.
- Carboxylic acid or carboxylic acid ester compound having fused-ring structure, method for producing the same, and use of compound16 Jun 2026US 12,655,112 B2FUJIFILM Corporation
- TEAD inhibitors and uses thereof16 Jun 2026US 12,655,150 B2Cedilla Therapeutics, Inc.
- Organic compound, solar cell, and application thereof27 Aug 2026US 2026/0255872 A1Contemporary Amperex Future Energy Research Institute (Shanghai) Limited
- Nanomaterials containing constrained lipids and uses thereof13 Aug 2026US 2026/0232587 A1Georgia Tech Research Corporation
- Phosphine ligands and their use in coupling reactions13 Aug 2026US 2026/0234175 A1BASF SE
- Plurality of host materials and organic electroluminescent device comprising the same6 Aug 2026US 2026/0231680 A1
- Composition and methods for inhibiting corrosion of metal during acidizing a wellbore in a subterranean formation for fracking9 Jul 2026US 2026/0193523 A1
Most cited
By later US patents
- Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases232US 6,180,632 B2Aventis Pharmaceuticals Products Inc. · 2001
- Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase226US 5,480,883 ARhone-Poulenc Rorer Pharmaceuticals Inc. · 1996
- Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases219US 6,482,834 B2Aventis Pharmaceuticals Inc. · 2002
- Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase209US 5,409,930 ARhone-Poulenc Rorer Pharmaceuticals Inc. · 1995
- Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases207US 6,245,760 B1Aventis Pharmaceuticals Products Inc. · 2001